Olivia is a healthcare consultant with over five years’ experience in market access consulting. She has led projects for pharmaceutical clients across multiple disease areas, with particular expertise in oncology and haematology. She supports clients in shaping access strategies, reimbursement planning, and product differentiation, working across diverse healthcare systems in Europe, Asia-Pacific, and Latin America. Olivia has strong expertise in HTA, evaluating product value and delivering value communication, drawing on her frontline clinical experience to ensure real-world insights inform strategy. She also brings experience in health policy-focused work, supporting system-level improvements in disease areas of high unmet need.
Before moving into consulting, Olivia spent six years as a clinical pharmacist in the NHS at a specialist cancer centre in London, managing patient care and supporting clinical trial set-up. She has a particular interest in advanced therapies, having both treated patients and contributed to multiple client projects in this space. Olivia has presented research at international conferences on treatment uptake and access trends and has contributed to global whitepapers exploring policy and system-level barriers in areas of high unmet need. She holds a Master of Pharmacy (MPharm) degree from the University of Bath and a postgraduate clinical diploma from University College London.